((3aR,4R,6aR)-6-methoxy-2,2-dimethyltetrahydrofuro[3,4-d][1,3]dioxol-4-yl)methyl 4-methylbenzenesulfonate

We are ((3aR,4R,6aR)-6-methoxy-2,2-dimethyltetrahydrofuro[3,4-d][1,3]dioxol-4-yl)methyl 4-methylbenzenesulfonate CAS:13007-50-6 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:((3aR,4R,6aR)-6-methoxy-2,2-dimethyltetrahydrofuro[3,4-d][1,3]dioxol-4-yl)methyl 4-methylbenzenesulfonate
CAS.NO:13007-50-6
Synonyms:((3aR,4R,6aR)-6-methoxy-2,2-dimethyltetrahydrofuro[3,4-d][1,3]dioxol-4-yl)methyl 4-methylbenzenesulfonate
methyl 5-tosyl-5-deoxy-2,3-O-isopropyliden-D-ribofuranoside
1-O-methyl-2,3-O-(1-methylethylidene)-5-O-(4-methylbenzenesulfonyl)-D-ribofuranoside
5-O-p-toluenesulfonyl-2,3-O-isopropylidene-β-D-ribofuranoside
1-O-methyl-2,3-O-(1-methylethylidene)-5-O-(4-methylbenzene sulfonyl)-D-ribofuranoside
methyl 5-(4-methylbenzenesulfonate)-2,3-O-(1-methylethylidene)-D-ribofuranoside
 
Physical and Chemical Properties:
Molecular Formula C16H22O7S
Molecular Weight 358.40700
 
Specification:
Appearance:White crystalline powder
Assay:≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Capecitabine(CAS:154361-50-9).

((3aR,4R,6aR)-6-methoxy-2,2-dimethyltetrahydrofuro[3,4-d][1,3]dioxol-4-yl)methyl 4-methylbenzenesulfonate


Related News: The Company’s first-of-kind approach involves engineering human iPSCs in a one-time genetic modification event and selecting a single engineered iPSC for maintenance as a clonal master iPSC line.110-53-2 The Company’s first-of-kind approach involves engineering human iPSCs in a one-time genetic modification event and selecting a single engineered iPSC for maintenance as a clonal master iPSC line.10,11-Dihydro-11-oxodibenzo[b,f][1,4]thiazepine CAS:3159-07-7 At present, Teva can produce more than 300 generic drugs, and the API department has approximately 650 authorized patents and patent applications worldwide. It is also the generic drug company with the most challenges in patenting ParagraphIV in the world.N1-(2-(dimethylamino)ethyl)-5-methoxy-N1-methyl-N4-(4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)benzene-1,2,4-triamine At present, Teva can produce more than 300 generic drugs, and the API department has approximately 650 authorized patents and patent applications worldwide. It is also the generic drug company with the most challenges in patenting ParagraphIV in the world.At present, Teva can produce more than 300 generic drugs, and the API department has approximately 650 authorized patents and patent applications worldwide. It is also the generic drug company with the most challenges in patenting ParagraphIV in the world.

Related Products
Product Name
N,N-Bis(2-hydroxyethyl)-p-phenylenediamine sulphate View Details
2-Amino-4′-fluorobenzophenone View Details
2,4-DIHYDRO-4-[(4-(4-HYDROXYPHENYL)-1-PIPERAZINYL)PHENYL]-2-(1-METHYLPROPYL)-3H-1,2,4-TRIAZOLE-3-ONE View Details
10-Fluorodecan-1-ol manufacturer (R)-glycidol manufacturer 2,5-Difluoronitrobenzene manufacturer VINYLMETHYLBIS(METHYLETHYLKETOXIMINO)SILANE manufacturer 1-(3-Chlorophenyl)-4-(3-Chloropropyl)Piperazine Hydrochloride manufacturer